Asia
Alteogen's Net Income Declines 14% in Q1
Alteogen (KOSDAQ:196170) posted first-quarter net income attributable to shareholders of 71.7 billion won, down 14% from 83.2 billion won a year earlier, according to a Friday filing with the Korea Exchange.Sales of the South Korean pharmaceutical firm fell 15% year over year to 71.6 billion won from 83.7 billion won.Shares of Alteogen fell over 4% at market close.
KOSDAQ:196170
